GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. (GEHC) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
gehc · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for GE HealthCare Technologies Inc. (GEHC) measures how much investors pay for each dollar of the company's trailing earnings. GEHC's current PE ratio of 19.59x is calculated by dividing its stock price of $64.67 by its TTM earnings per share of $3.30. +16.3% elevated vs 5Y avg 16.9x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2019 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 7 fiscal years · Front-end computedMinQ1 · 25%17.9x
MedianQ3 · 75%22.4x
Max
At 19.59x, GEHC's current P/E is higher than in 86% of its annual fiscal year readings over the past 7 years — historically elevated.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Healthcare Information Services · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
GE HealthCare Technologies Inc.You GEHC | $29.4B | 19.59x | -35.5% | $3.30 |
 Agilent Technologies, Inc. A | $38.3B | 31.79x | +4.6% | $4.60 |
 Alcon Inc. ALC | $32.6B | 39.80x | +30.9% | $1.98 |
 Cardinal Health, Inc. CAH | $48.2B | 25.94x | -14.7% | $6.48 |
 Humana Inc. HUM | $42.0B | 25.97x | -14.6% | $9.86 |
 Insmed Incorporated INSM | $20.4B | N/A | — | -$5.98 |
 IQVIA Holdings Inc. IQV | $30.6B | 28.49x | -6.3% | $7.91 |
Industry Average 5 peers with valid PE | — | 30.40x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 17.97x | $4.56 | +0.4% | |
2024-12-31 FY2024 | 17.89x | $4.37 | -20.3% | |
2023-12-31 FY2023 | 22.44x | $3.45 | +62.2% | |
2022-12-31 FY2022 | 13.83x | $4.22 | +13.9% | |
2021-12-31 FY2021 | 12.14x | $4.94 | +516.2% | |
2020-12-31 FY2020 | 1.97x | $30.45 | -89.0% | |
2019-12-31 FY2019 | 17.90x | $3.35 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for GE HealthCare Technologies Inc. (GEHC) measures how much investors pay for each dollar of the company's trailing earnings. GEHC's current PE ratio of 19.59x is calculated by dividing its stock price of $64.67 by its TTM earnings per share of $3.30.
Frequently asked questions
GEHC pe ratio · 6 questionsGEHC's current PE ratio is 19.59x as of 2026-06-08, based on a stock price of $64.67 and TTM EPS of $3.30. Data sourced from Financial Modeling Prep via GEHC's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · GE HealthCare Technologies Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08